Notification That Annual Report Will Be Submitted Late (nt 10-k)
April 01 2015 - 5:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
Commission File Number: 333-173873
Notification of Late Filing
(Check one): |
|
[X] Form 10-K Form 20-F o Form 11-K o Form 10-Q Form 10-D o Form N-SAR o Form N-CSR |
|
|
|
|
|
For Period Ended: |
December 31, 2014 |
|
|
|
|
|
o Transition Report on Form 10-K |
|
|
|
|
|
o Transition Report on Form 20-F |
|
|
|
|
|
o Transition Report on Form 11-K |
|
|
|
|
|
o Transition Report on Form 10-Q |
|
|
|
|
|
o Transition Report on Form N-SAR |
|
|
|
|
|
For the Transition Period Ended: N/A |
PART I
REGISTRANT INFORMATION
MED-CANNABIS PHARMA INC.
Full name of Registrant
_______________________
Former Name if Applicable
2544 Tarpley Road Suite 112
Address of principal executive office
(Street and Number)
Carrollton, TX 75006
City, State and Zip Code
PART II
RULES 12b-25(b) and (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Tule 12b-25(b),
the following should be completed. (Check appropriate box.) x
Yes o No
x |
(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense. |
x |
(b) The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or N-SAR, or portion thereof, will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date. |
o |
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART III
NARRATIVE
State below in reasonable detail the reasons why Form 10-K,
11-K, 20-F, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period.
The Registrant’s annual report
on Form 10-K for the period ended December 31, 2014 will be filed on or before the fifteenth calendar day following the prescribed
due date. The reason for the delay is that the Registrant did not obtain all information prior to filing date and attorney
and accountant could not complete the required legal information and financial statements and management could not complete Management’s
Discussion and Analysis of such financial statements by March 31, 2015.
PART IV
OTHER INFORMATION
(1) Name and telephone number
of person to contact in regard to this notification:
Garrett Vogel |
214 |
336-8025 |
(Name) |
(Area Code) |
(Telephone Number) |
(2) |
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). x Yes o No |
(3) |
Is it anticipated that any significant change in results of operation for the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? o Yes x No |
If so, attach an explanation
of anticipated change, both narratively and quantitatively, and if appropriate, state the reasons why a reasonable estimate of
the results cannot be made.
MED-CANNABIS PHARMA INC.
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed
on its behalf by the undersigned hereunto duly authorized.
Date: March 31, 2015 |
By: /s/ Garrett Vogel
Garrett Vogel CFO |
Instruction: The form may
be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title
of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf
of the registrant by an authorized representative (other than executive officer), evidence of the representative’s authority
to sign on behalf of the registrant shall be filed with the form.
ATTENTION
Intentional misstatements or omissions
of fact constitute Federal criminal violations. (See 18 U.S.C. 1001)
Pegasus Companies (CE) (USOTC:PEGX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pegasus Companies (CE) (USOTC:PEGX)
Historical Stock Chart
From Sep 2023 to Sep 2024